Events
One of the objectives of the Telemetric and Holter ECG Warehouse Initiative is to spawn collaborative research projects with various organizations in the United States and around the world. The information related to the THEW research activities is posted on this page.
The information below lists the various events starting January 2008
Up Coming
Second Telemetric and Holter ECG Warehouse Event
FREE REGISTRATION and MEETING AGENDA WILL BE AVAILABLE SOON
Location :
FDA Headquarter - White Oak campus, Silver Spring, MD.
Date : April 29th, 2009
Past
Integrating Pre-Clinical & Clinical Issues in Cardiac Safety: Translational Medicine Meets the Critical Path October 6th-7th
Bethesda, Maryland
Presenter: JP Couderc, PhD
“Computerized Method to Detect the QT Prolongation Induced by Moxifloxacin: Reporting the Results From Five-Drug-Safety Trials from the FDA Digital ECG Repository”
DIA – 3rd Annual Cardiac Safety Conference scheduled for December 4 – 5, 2008 taking place at the Hotel Hilton Barcelona in Spain.
December 4, 2008 from 11.00 – 12.30 CET
Session name: “Computerised Methodologies to Asses Cardiac Arrhythmia Vulnerability”. Chair: Boaz Mendezelevski, MD, Cardiac Safety Consultant, Cardiac Safety Consultants Ltd., UK.
Presenter: JP Couderc, PhD
Presentation of the THEW Initiative to the ESGCO Members.
The European Study Group on Cardiovascular Oscillations (ESGCO) was created during an Educational Training Course of the European Society of Cardiology in 1998 by Alberto Malliani, Tudor Griffith, Pontus Persson and Bernard Swynghedauw.
The goal of the Study Group is to promote basic research on cardiovascular oscillations, including heart rate and blood pressure variations, contractility changes, oscillations in microcirculation, calcium waves and ion movements.
Location: Parma , Italy
Presenter: JP Couderc, PhD
DIA: Evolution of Drug Development and Cardiac Repolarization.
In his presentation about the "Scientific Efforts to Further Define CV Safety". Dr. Stockbridge will introduce the THEW Initiative.
Location: Washington, USA
Presenter: Dr. Norman Stockbridge
Download the presentation:
New Biomarkers - The path to scientific and Regulatory Approval. B. Mendzelevski
Presentation of the THEW project and the recent progress related to its implementation.
Location Miami, FL
The Telemetric and
Holter Warehouse Project: - JP Couderc (URMC)
January 16th, 2008 -1st Telemetric and Holter ECG Warehouse Event Location: FDA Campus, Springfield, MD The first meeting related to the THEW project was a successful event with 44 registrants from for-profit and not-for-profit organizations. The meeting included a presentation of the THEW project and a session for scientific presentations during which various companies such as Mortara Instrument, GE-Health Care and others presented the latest technologies for analysis of the QT interval from Holter and continuous ECG signals. Download the documentation and presentations:
-
-
The Telemetric and
Holter Warehouse Project - JP Couderc (URMC)
-
Interest of Using Holter Technologies in Cardiac Safety Studies
Continuous
12-lead ECG Recording in Clinical Trials - Justin Mortara (Mortara
Instrument) Holter Technology
in Drug Safety: A Technical Point of View - Fabio Badilini (AMPS
LLC) Advantages of 12-lead
Holter Technology in TQT Studies - Marek Malik (on behalf of GE
Health Care Inc.) ECG Restitution
of the Beat-to-beat QT-TQ Intervals in Humans -Anthony Fossa (Pfizer
Inc.) Holter-Based Methods
for Improved Cardiac Safety Assessment - Mikael Totterman (iCardiac
Technologies Inc.) CSRC: Involvement and Update - P. Kligfield
-
[11/01/2008] Striving to advance the field of cardiac safety, the THEW initiative is developed for facilitating collaborative discussions between THEW members, and for leveraging resources to implement joint projects among FDA, University of Rochester (UR), and other public and private stakeholders. The THEW is led by individuals from the UR, the Commissioner Office of the FDA, the Center for Drug Evaluation and Research, and the Center for Devices and Radiological Health. More...
[05/27/2008] Dr. Janet Woodcock (Director, CDER-FDA) and Dr. Norman Stockbridge (Acting Director for the Division of Cardiovascular and Renal Products, CDER-FDA) signed a Letter of Agreement officially starting the partnership between the FDA and University of Rochester for the THEW initiative. More...